Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
02/11/1999 | DE19733389A1 Mittel zur Expression und zum Nachweis eines ein HPOL-Epitop und ein Polypeptid umfassenden Fusionspolypeptids Means for expression and detection of a HPOL epitope and a polypeptide comprising the fusion polypeptide |
02/11/1999 | DE19729591A1 Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen Agents for the treatment and / or prophylaxis of microcirculation disorders |
02/11/1999 | DE19728737C1 Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten A method for the detection and determination of GnRH receptors and the use of GnRH agonists and GnRH-antagonists for the treatment of a tumor originating in the brain and / or nervous system and / or the meninges |
02/11/1999 | CA2493240A1 Methods for detecting or assaying virus |
02/11/1999 | CA2338865A1 Methods for detecting binding events using multiple binding partners and muliple targets |
02/11/1999 | CA2299623A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs |
02/11/1999 | CA2299276A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
02/11/1999 | CA2299256A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
02/11/1999 | CA2299055A1 Novel molecules of the tango-77 related protein family and uses thereof |
02/11/1999 | CA2298852A1 83 human secreted proteins |
02/11/1999 | CA2298766A1 Human longevity-assurance protein homologs |
02/11/1999 | CA2298573A1 Synaptojanin isoform |
02/11/1999 | CA2298538A1 Recombinant dimeric envelope vaccine against flaviviral infection |
02/11/1999 | CA2297745A1 Oxidized styrenic polymers for dna binding |
02/11/1999 | CA2297555A1 Collagen-peptide assay method |
02/11/1999 | CA2297489A1 Novel bone mineralization proteins, dna, vectors, expression systems |
02/11/1999 | CA2294650A1 Starch debranching enzymes |
02/11/1999 | CA2239836A1 Novel arginine deiminase |
02/11/1999 | CA2239813A1 Novel nrdd |
02/10/1999 | EP0896061A2 RpoA gene from Staphylococcus aureus |
02/10/1999 | EP0896060A2 RpoA gene from Staphylococcus aureus |
02/10/1999 | EP0896058A1 Novel semaphorin z and gene encoding the same |
02/10/1999 | EP0896055A2 Apoptosis inducing protein and gene encoding the same |
02/10/1999 | EP0895543A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
02/10/1999 | EP0556272B1 Therapeutic and diagnostic methods using total leukocyte surface antigens |
02/10/1999 | CN1207811A Method of diagnosing and treating epithelioma |
02/10/1999 | CN1207395A Anti-FAS antibodies |
02/09/1999 | US5869640 Nucleic acids encoding D-type cyclins and hybridization probes |
02/09/1999 | US5869638 Bone-related cadherin-like protein and process for its production |
02/09/1999 | US5869637 Human Kallikrein |
02/09/1999 | US5869636 Recombinant cell line expressing polypetide for anticarcinogenic and antitumor agents and vaccines |
02/09/1999 | US5869622 Monoclonal antibodies to the pur protein |
02/09/1999 | US5869621 A human antibody, expressed in the thymus, that binds an at rich sequence proteins in the nuclear scaffold; unwinding properties in relieving negative superhelical strains that occur in chromatin loops; use as probe for atc sequences |
02/09/1999 | US5869620 Multivalent antigen-binding proteins |
02/09/1999 | US5869619 Modified antibody variable domains |
02/09/1999 | US5869618 For diagnosis of cancers related to erbb-2 oncogene expression |
02/09/1999 | US5869612 Amino acid sequence of isolated protein involved in post-receptor signal transduction; treatment of rheumatoid arthritis and septic shock |
02/09/1999 | US5869610 Isolated polypeptide identified as a cytokine receptor containing extracellular, transmembrane and intracellular domains; prenatal testing and cancer diagnosis |
02/09/1999 | US5869609 G protein coupled glutamate receptors |
02/09/1999 | US5869603 Amino acid sequences of synthetic peptides binding to neutralizing antibodies against recombinant interferon-beta; for detection and inhibition of antibodies in patients |
02/09/1999 | US5869445 Methods for eliciting or enhancing reactivity to HER-2/neu protein |
02/09/1999 | US5869349 Pretreatment with acid prior to immobilization on silaceous support increases antigen-binding capacity |
02/09/1999 | US5869348 Methods for the preparation of antibodies directed against dithiocarbamates and the use thereof for detection of nitric oxide in body fluids |
02/09/1999 | US5869333 Ryegrass pollen allergen |
02/09/1999 | US5869331 Target cell specific chimeric spleen necrosis virus viral particles having antigenic binding and natural viral proteins; gene therapy |
02/09/1999 | US5869292 Producing genetically engineered protein by replacing at least one acidic region of factor viii with acidic region of hirudin or heparin cofactor ii; increased coagulant activity |
02/09/1999 | US5869290 Cayae1 polynucleotides |
02/09/1999 | US5869286 Receptor that binds IL-17 |
02/09/1999 | US5869282 Nucleotide and protein sequences of the serrate gene and methods based thereon |
02/09/1999 | US5869281 For culturing and screening for modulators of receptor; glucoma, synchronization of animal estrus cycles, antitumor and antiprolferative agents |
02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
02/09/1999 | US5869268 Anti-hanganutzui-deicher human monoclonal igg antibody; for anticarcinogenic and antitumors agents and diagnosis |
02/09/1999 | US5869265 Screening modulators by contacting recombinant cells which express cotransporter with substance, determining increase or decrease in activity; anticholesterol agents; antidiabetic agents; liver disease; crohn's disease |
02/09/1999 | US5869264 Immunoassays for and immunopurification of interferon-induced human protein |
02/09/1999 | US5869263 Lymphocyte chemoattractant factor and uses thereof |
02/09/1999 | US5869262 Quantitative immunoassay by contacting serum from patient with antibodies against circulating intercellular adhesion molecule-r, detecting binding; higher levels indicate progression of systematic lupus erythematosus |
02/09/1999 | US5869235 Dna coding for the coat protein of virus isolated from infected vine plants; for detection of vrial infection by reverse transcription polymerase chain reaction and southern blotting |
02/09/1999 | US5869232 Amino acid sequence of antibody binding to specific antigen (or hapten) covalently linked to second amino acid sequence to which a second antibody binds; redirecting specificity of antibody |
02/09/1999 | US5869064 Protein rib, a cell surface protein that confers immunity to many strains of the group B Streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
02/09/1999 | US5869055 Anti-inflammatory CD14 polypeptides |
02/09/1999 | US5869053 5T4 antigen from human trophoblasts |
02/09/1999 | US5869050 Administering to patient antibody against b7 antigen and immunosuppressive agent in synergistic mixture; treatment of transplant rejection, graft versus host disease, rheumatoid arthritis |
02/09/1999 | US5869049 Methods of inducing T cell unresponsiveness to bone marrow with gp39 antagonists |
02/09/1999 | US5869048 Method of treating ulcerative colitis with a monoclonal antibody |
02/09/1999 | US5869046 Altered polypeptides with increased half-life |
02/09/1999 | US5869045 Polypeptide comprising antigen-binding region of monoclonal antibody produced by specified hybridoma |
02/09/1999 | CA1340387C Heterobifunctional coupling agents |
02/08/1999 | CA2239223A1 Novel rpoa |
02/08/1999 | CA2239222A1 Novel rpoa |
02/06/1999 | CA2239256A1 Novel lgt |
02/05/1999 | CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
02/05/1999 | CA2239270A1 Novel phosphoribosyl transferase |
02/05/1999 | CA2238673A1 Novel aminopeptidase |
02/05/1999 | CA2212315A1 Pharmaceutical composition with neurotrophic-like biological activity |
02/04/1999 | WO1999005291A2 Aggrecan degrading metallo proteases |
02/04/1999 | WO1999005282A1 Non-b non-c non-g hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus |
02/04/1999 | WO1999005280A1 Mammalian cytokine: interleukin-b30 and related reagents |
02/04/1999 | WO1999005275A1 Secreted proteins encoded by human chromosome 13 |
02/04/1999 | WO1999005261A1 Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen) |
02/04/1999 | WO1999005176A1 Monospecific antibody reactive with fibrinogen and fibrinopeptide b |
02/04/1999 | WO1999005175A2 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1) |
02/04/1999 | WO1999005174A1 The ha-1 antigen |
02/04/1999 | WO1999005173A1 The ha-1 antigen |
02/04/1999 | WO1999005171A1 NOVEL ESTROGEN RECEPTOR β AND ISOFORMS |
02/04/1999 | WO1999005170A1 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
02/04/1999 | WO1999005169A1 Epitopes of shigella like toxin and their use as vaccine and in diagnosis |
02/04/1999 | WO1999004820A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
02/04/1999 | WO1998051337A3 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors |
02/04/1999 | WO1998050433A3 Human monoclonal antibodies to epidermal growth factor receptor |
02/04/1999 | WO1998050424A3 Human serine protease precursor |
02/04/1999 | CA2298887A1 The ha-1 antigen |
02/04/1999 | CA2298103A1 Non-b, non-c, non-g hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
02/04/1999 | CA2298053A1 Novel estrogen receptor .beta. and isoforms |
02/04/1999 | CA2297907A1 Human estrogen receptor beta |
02/04/1999 | CA2296798A1 Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents |
02/04/1999 | CA2296292A1 Secreted proteins encoded by human chromosome 13 |
02/04/1999 | CA2239267A1 Novel compounds |
02/03/1999 | EP0894863A1 A YAK-1 related serine/threonine protein kinase-HTLAR33 |
02/03/1999 | EP0894862A2 Novel CysS |
02/03/1999 | EP0894861A2 Glycogen phosphorylase from Streptococcus pneumoniae |